Treatment of chronic bacterial infections: Bacteriophages as a potential treatment option
Life-threatening human infectious diseases caused by bacterial pathogens are now re-emerging, in part due to increased resistance to antibiotics.
Susana Cunha concluded her BSc degree in Biology and Geology in 2019 and her MSc degree in Applied Biochemistry – Biomedicine in 2022, both at School of Sciences, University of Minho. In 2020, she developed her master thesis related with the “Detection and quantification of cell-free Nucleic Acids (cfNAs) in blood samples of patients with Acute Myeloid Leukaemia (AML): Protocol optimization” at the Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho. During her master studies, she focused on the role of exosomes and cfNAs as biomarkers for AML and high-yield cfNAs isolation from blood samples of AML patients. More importantly, her preliminary results, showed a characteristic pattern of cfNAs, which could be used as a potential biomarker of AML. From 2020, to the present she collaborated in research for scientific publications at ICVS. She was involved on the project MicroTreat – “Biomimetic microenvironment for the study and development of targeted therapies in hematological malignances”. More recently she received a Research Fellowship within on the project FITTED – “A flexible platform for generating synthetic virus to control infectious diseases”, financed by “La Caixa Foundation”. Currently their research, focused on the antibacterial properties of certain viruses, named bacteriophages (phages).
Susana Cunha concluded her BSc degree in Biology and Geology in 2019 and her MSc degree in Applied Biochemistry – Biomedicine in 2022, both at School of Sciences, University of Minho. In 2020, she developed her master thesis related with the “Detection and quantification of cell-free Nucleic Acids (cfNAs) in blood samples of patients with Acute Myeloid Leukaemia (AML): Protocol optimization” at the Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho. During her master studies, she focused on the role of exosomes and cfNAs as biomarkers for AML and high-yield cfNAs isolation from blood samples of AML patients. More importantly, her preliminary results, showed a characteristic pattern of cfNAs, which could be used as a potential biomarker of AML. From 2020, to the present she collaborated in research for scientific publications at ICVS. She was involved on the project MicroTreat – “Biomimetic microenvironment for the study and development of targeted therapies in hematological malignances”. More recently she received a Research Fellowship within on the project FITTED – “A flexible platform for generating synthetic virus to control infectious diseases”, financed by “La Caixa Foundation”. Currently their research, focused on the antibacterial properties of certain viruses, named bacteriophages (phages).
Life-threatening human infectious diseases caused by bacterial pathogens are now re-emerging, in part due to increased resistance to antibiotics.
Phone: +351 253 604 967
Fax: +351 253 604 809
Email: icvs.sec@med.uminho.pt
Life and Health Sciences
Research Institute (ICVS)
School of Medicine,
University of Minho,
Campus de Gualtar
4710-057 Braga
Portugal
Copyright ©2022 ICVS. All Rights Reserved
Copyright ©2022 ICVS. All Rights Reserved
Life and Health Sciences
Research Institute (ICVS)
School of Medicine,
University of Minho,
Campus de Gualtar
4710-057 Braga
Portugal
Copyright ©2022 ICVS. All Rights Reserved
Life and Health Sciences
Research Institute (ICVS)
School of Medicine,
University of Minho,
Campus de Gualtar
4710-057 Braga
Portugal